Novel ‘quadpill’ for lowering BP trumps standard monotherapy: Aus trial
Researchers report on the QUARTET study of quarter-doses of four antihypertensives in one capsule
AusDoc brings you the latest news from the European Society of Cardiology Congress 2021.
Initiation of a quadruple combination of antihypertensive agents in quarter doses is a more effective way to bring blood pressure under control quickly than standard monotherapy with irbesartan, Australian cardiologists have shown.